Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 494

1.

Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.

Ang KK, Sturgis EM.

Semin Radiat Oncol. 2012 Apr;22(2):128-42. doi: 10.1016/j.semradonc.2011.12.004. Review.

PMID:
22385920
2.

Human papillomavirus: changing paradigms in oropharyngeal cancer.

Adelstein DJ, Rodriguez CP.

Curr Oncol Rep. 2010 Mar;12(2):115-20. doi: 10.1007/s11912-010-0084-5.

PMID:
20425596
3.

HPV-associated head and neck cancer: a virus-related cancer epidemic.

Marur S, D'Souza G, Westra WH, Forastiere AA.

Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5. Review.

PMID:
20451455
4.

Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.

Wang XI, Thomas J, Zhang S.

Ann Diagn Pathol. 2012 Jan;16(1):7-12. doi: 10.1016/j.anndiagpath.2011.07.003. Epub 2011 Oct 15.

PMID:
22001331
5.

The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?

Sturgis EM, Ang KK.

J Natl Compr Canc Netw. 2011 Jun 1;9(6):665-73. Review.

PMID:
21636538
6.

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI.

Laryngoscope. 2009 Aug;119(8):1542-9. doi: 10.1002/lary.20533.

PMID:
19522004
7.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML.

N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.

8.

Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.

Haughey BH, Sinha P.

Laryngoscope. 2012 Sep;122 Suppl 2:S13-33. doi: 10.1002/lary.23493.

PMID:
22926949
9.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA.

J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9.

10.

Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.

Marur S, Burtness B.

Curr Opin Oncol. 2014 May;26(3):252-8. doi: 10.1097/CCO.0000000000000072. Review.

PMID:
24626127
11.

HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.

Kraft S, Faquin WC, Krane JF.

Am J Surg Pathol. 2012 Mar;36(3):321-30. doi: 10.1097/PAS.0b013e31823f2f17.

PMID:
22301491
12.

Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.

Jain KS, Sikora AG, Baxi SS, Morris LG.

Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19.

13.

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A.

J Clin Oncol. 2006 Feb 10;24(5):736-47. Epub 2006 Jan 9.

14.

The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.

Oguejiofor KK, Hall JS, Mani N, Douglas C, Slevin NJ, Homer J, Hall G, West CM.

Clin Oncol (R Coll Radiol). 2013 Nov;25(11):630-8. doi: 10.1016/j.clon.2013.07.003. Epub 2013 Jul 31.

PMID:
23916365
15.

What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?

Urban D, Corry J, Rischin D.

Cancer. 2014 May 15;120(10):1462-70. doi: 10.1002/cncr.28595. Epub 2014 Feb 27. Review.

16.

Human papillomavirus and oropharyngeal cancer: what you need to know in 2009.

Gillespie MB, Rubinchik S, Hoel B, Sutkowski N.

Curr Treat Options Oncol. 2009 Dec;10(5-6):296-307. doi: 10.1007/s11864-009-0113-5. Epub 2009 Sep 19. Review.

PMID:
19768554
17.

Association of cystic neck metastases and human papillomavirus-positive oropharyngeal squamous cell carcinoma.

McHugh JB.

Arch Pathol Lab Med. 2009 Nov;133(11):1798-803. doi: 10.1043/1543-2165-133.11.1798.

PMID:
19886714
18.
19.

Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.

Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW.

Clin Cancer Res. 2010 Apr 1;16(7):2138-46. doi: 10.1158/1078-0432.CCR-09-3185. Epub 2010 Mar 16.

20.

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N, Le QT.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):553-61. doi: 10.1016/j.ijrobp.2009.02.015.

Items per page

Supplemental Content

Write to the Help Desk